Cargando…
Prognosis in HIV-infected patients with non-small cell lung cancer
BACKGROUND: We conducted a population-based study to evaluate whether non-small cell lung cancer (NSCLC) prognosis was worse in HIV-infected compared with HIV-uninfected patients. METHODS: Using the Surveillance, Epidemiology and End Results (SEER) registry linked to Medicare claims, we identified 2...
Autores principales: | Sigel, K, Crothers, K, Dubrow, R, Krauskopf, K, Jao, J, Sigel, C, Moskowitz, A, Wisnivesky, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790190/ https://www.ncbi.nlm.nih.gov/pubmed/24022194 http://dx.doi.org/10.1038/bjc.2013.545 |
Ejemplares similares
-
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4(+) cell count at least 500 cells/μl
por: Kong, Chung Yin, et al.
Publicado: (2018) -
Clinically significant mutations in HIV-infected patients with lung adenocarcinoma
por: Thaler, Jonathan, et al.
Publicado: (2017) -
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities
por: Sigel, Keith, et al.
Publicado: (2021) -
Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden
por: Criss, Steven D., et al.
Publicado: (2020) -
The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study
por: Leiter, Amanda, et al.
Publicado: (2022)